Rac inhibitors
US10472352B2 · kind B2 · utility
0Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2018 |
| Grant date | Nov 12, 2019 |
| Priority date | — |
| Expiry date | Jul 25, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds that act as pan-Rac inhibitors, compositions including the compounds, and methods of using the compounds. In particular, the compounds are useful for treating certain cancers such as breast cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.